Beta

Hca healthcare, inc.HCA.US Overview

US StockHealthcare
(No presentation for HCA)
OverviewAI AnalysisFinancialsFinancial ForecastStock SentimentalInstitutionsTradingView Chart

Ticker

Value

empty

There is no following symbol in this watchlist.

HCA AI Insights

HCA Overall Performance

HCA AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

HCA Recent Performance

-3.11%

Hca healthcare, inc.

-1.10%

Avg of Sector

-0.49%

S&P500

HCA PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

Check HCA's Trend

HCA Key Information

HCA Valuation Metrics

HCA Profile

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Price of HCA

HCA FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

HCA Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
30.39
PE Ratio (TTM)
16.72
Forward PE
15.55
PS Ratio (TTM)
1.28
PB Ratio
291.34
Price-to-FCF
12.57
METRIC
VALUE
vs. INDUSTRY
Gross Margin
34.92%
Net Margin
8.89%
Revenue Growth (YoY)
6.71%
Profit Growth (YoY)
-8.88%
3-Year Revenue Growth
7.02%
3-Year Profit Growth
-22.22%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
30.39
PE Ratio (TTM)
16.72
Forward PE
15.55
PS Ratio (TTM)
1.28
PB Ratio
291.34
Price-to-FCF
12.57
Gross Margin
34.92%
Net Margin
8.89%
Revenue Growth (YoY)
6.71%
Profit Growth (YoY)
-8.88%
3-Year Revenue Growth
7.02%
3-Year Profit Growth
-22.22%
  • When is HCA's latest earnings report released?

    The most recent financial report for Hca healthcare, inc. (HCA) covers the period of 2026Q1 and was published on 2026/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating HCA's short-term business performance and financial health. For the latest updates on HCA's earnings releases, visit this page regularly.

  • Where does HCA fall in the P/E River chart?

    According to historical valuation range analysis, Hca healthcare, inc. (HCA)'s current price-to-earnings (P/E) ratio is 16.55, placing it in the Watch zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of HCA?

    According to the latest financial report, Hca healthcare, inc. (HCA) reported an Operating Profit of 2.86B with an Operating Margin of 14.98% this period, representing a growth of 0.28% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is HCA's revenue growth?

    In the latest financial report, Hca healthcare, inc. (HCA) announced revenue of 19.11B, with a Year-Over-Year growth rate of 4.3%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does HCA have?

    As of the end of the reporting period, Hca healthcare, inc. (HCA) had total debt of 10.35B, with a debt ratio of 0.11. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does HCA have?

    At the end of the period, Hca healthcare, inc. (HCA) held Total Cash and Cash Equivalents of 940M, accounting for 0.01 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does HCA go with three margins increasing?

    In the latest report, Hca healthcare, inc. (HCA) achieved the “three margins increasing” benchmark, with a gross margin of 14.98%%, operating margin of 14.98%%, and net margin of 8.48%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess HCA's profit trajectory and future growth potential.

  • Is HCA's EPS continuing to grow?

    According to the past four quarterly reports, Hca healthcare, inc. (HCA)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 7.15. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of HCA?

    Hca healthcare, inc. (HCA)'s Free Cash Flow (FCF) for the period is 895M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 35.61% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of HCA?

    The latest valuation data shows Hca healthcare, inc. (HCA) has a Price-To-Earnings (PE) ratio of 16.55 and a Price/Earnings-To-Growth (PEG) ratio of -1.36. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.